Sakamoto Y - Search Results

1

Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer.

Kusumoto T, Sunami E, Ota M, Yoshida K, Sakamoto Y, Tomita N, Maeda A, Mochizuki I, Okabe M, Kunieda K, Yamauchi J, Itabashi M, Kotake K, Takahashi K, Baba H, Boku N, Aiba K, Ishiguro M, Morita S, Sugihara K. Kusumoto T, et al. Among authors: sakamoto y. Clin Colorectal Cancer. 2018 Jun;17(2):e153-e161. doi: 10.1016/j.clcc.2017.10.015. Epub 2017 Nov 1. Clin Colorectal Cancer. 2018. PMID: 29249584 Free article. Clinical Trial.

2

A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.

Matsuda C, Ishiguro M, Teramukai S, Kajiwara Y, Fujii S, Kinugasa Y, Nakamoto Y, Kotake M, Sakamoto Y, Kurachi K, Maeda A, Komori K, Tomita N, Shimada Y, Takahashi K, Kotake K, Watanabe M, Mochizuki H, Nakagawa Y, Sugihara K; SACURA Study Group. Matsuda C, et al. Among authors: sakamoto y. Eur J Cancer. 2018 Jun;96:54-63. doi: 10.1016/j.ejca.2018.03.009. Epub 2018 Apr 17. Eur J Cancer. 2018. PMID: 29677641 Free article. Clinical Trial.

3

S-1 and Oxaliplatin Versus Tegafur-uracil and Leucovorin as Postoperative Adjuvant Chemotherapy in Patients With High-risk Stage III Colon Cancer (ACTS-CC 02): A Randomized, Open-label, Multicenter, Phase III Superiority Trial.

Sunami E, Kusumoto T, Ota M, Sakamoto Y, Yoshida K, Tomita N, Maeda A, Teshima J, Okabe M, Tanaka C, Yamauchi J, Itabashi M, Kotake K, Takahashi K, Baba H, Boku N, Aiba K, Ishiguro M, Morita S, Takenaka N, Okude R, Sugihara K. Sunami E, et al. Among authors: sakamoto y. Clin Colorectal Cancer. 2020 Mar;19(1):22-31.e6. doi: 10.1016/j.clcc.2019.10.002. Epub 2019 Oct 18. Clin Colorectal Cancer. 2020. PMID: 31917122 Free article. Clinical Trial.

4

[Ten cases of locally advanced rectal cancer that were treated with preoperative chemotherapy with S-1 plus oxaliplatin].

Yokoyama H, Koyama M, Muroya T, Morohashi H, Sakamoto Y, Takahashi S, Murata A, Terui K, Hakamada K. Yokoyama H, et al. Among authors: sakamoto y. Gan To Kagaku Ryoho. 2013 Nov;40(12):1971-3. Gan To Kagaku Ryoho. 2013. PMID: 24393983 Japanese.

5

[A Case of Laparoscopic Surgery for Rectal Cancer with Synchronous Lung Metastases after Chemotherapy].

Yoshida T, Morohashi H, Ichinohe D, Yoshida E, Okano K, Nagase H, Akasaka H, Jin H, Miura T, Sakamoto Y, Hakamada K. Yoshida T, et al. Among authors: sakamoto y. Gan To Kagaku Ryoho. 2016 Nov;43(12):2320-2322. Gan To Kagaku Ryoho. 2016. PMID: 28133308 Japanese.

6

[Treatment Strategy for Stage Ⅳ Rectal Cancer].

Sakamoto Y, Morohashi H, Yoshida E, Kimura T, Koyama M, Murata A, Hakamada K. Sakamoto Y, et al. Gan To Kagaku Ryoho. 2015 Oct;42(10):1313-5. Gan To Kagaku Ryoho. 2015. PMID: 26489583 Japanese.

7

[A Case of Pathological Complete Response after Neoadjuvant Chemotherapy(S-1 plus Oxaliplatin)and Laparoscopic Low Anterior Resection for Rectal Cancer].

Ichinohe D, Morohashi H, Umetsu S, Yoshida T, Wakasa Y, Odagiri T, Kimura T, Suto A, Saito T, Yoshida E, Akasaka H, Jin H, Miura T, Sakamoto Y, Hakamada K. Ichinohe D, et al. Among authors: sakamoto y. Gan To Kagaku Ryoho. 2016 Nov;43(12):1715-1717. Gan To Kagaku Ryoho. 2016. PMID: 28133108 Japanese.

8

[A case of lung metastases after surgery for colon cancer demonstrating complete response for more than six years after treatment with UFT/LV].

Sakamoto Y, Murata A, Koyama M, Morohashi H, Tsutsumi S, Yonaiyama S, Morita T, Hakamada K. Sakamoto Y, et al. Gan To Kagaku Ryoho. 2011 Nov;38(12):2520-2. Gan To Kagaku Ryoho. 2011. PMID: 22202433 Japanese.

9

[Evaluation of the Therapeutic Effect of Using Dual-Energy CT for Rectal Cancer after Neoadjuvant Chemotherapy].

Morohashi H, Sakamoto Y, Ichinohe D, Jin H, Miura T, Tsushima F, Ono S, Hakamada K. Morohashi H, et al. Among authors: sakamoto y. Gan To Kagaku Ryoho. 2016 Nov;43(12):1482-1484. Gan To Kagaku Ryoho. 2016. PMID: 28133030 Japanese.

10

A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.

Sakamoto Y, Morohashi H, Miura T, Tsutsumi S, Takahashi S, Hirama K, Wakiya T, Hakamada K. Sakamoto Y, et al. Dis Colon Rectum. 2022 May 1;65(5):663-671. doi: 10.1097/DCR.0000000000001927. Dis Colon Rectum. 2022. PMID: 33833145 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,533 results

Search Page

Filters